Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies

Bibliographic Details
Main Authors:	Joseph F Merola, Atul Deodhar, Philip J Mease, Shihong Sheng, Iain B McInnes, Soumya D Chakravarty, Elena Schiopu, Yanli Wang, Wolf-Henning Boehncke, Christopher T Ritchlin, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, May Shawi, Stephen Xu, John Tesser
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-03-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/8/1/e002195.full

Internet